MT-8554 low dose

DRUG4 trials

Sponsors

Tanabe Pharma Corporation, Tanabe Pharma America, Inc.

Conditions

HealthyHealthy VolunteerPainful Diabetic Peripheral NeuropathyVasomotor Symptoms

Phase 1

A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects

CompletedNCT02536209

Tanabe Pharma CorporationHealthy

Start: 2015-08-31End: 2015-11-30Updated: 2025-12-22

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms

CompletedNCT02803268

Tanabe Pharma CorporationVasomotor Symptoms

Start: 2016-06-30End: 2017-01-31Updated: 2025-12-22

Definitive QT Study With MT-8554

CompletedNCT03471130

Tanabe Pharma America, Inc.Healthy Volunteer

Start: 2018-04-23End: 2018-10-19Updated: 2025-12-17

Phase 2

Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy

CompletedNCT03172598

Tanabe Pharma CorporationPainful Diabetic Peripheral Neuropathy

Start: 2017-07-25End: 2018-08-08Updated: 2025-12-22